Style | Citing Format |
---|---|
MLA | Shaghaghi Z, et al.. "Etodolac Enhances the Radiosensitivity of Irradiated Ht-29 Human Colorectal Cancer Cells." Current Radiopharmaceuticals, vol. 15, no. 3, 2022, pp. 242-248. |
APA | Shaghaghi Z, Polgardani NZ, Abbasi S, Albooyeh H, Dastranj L, Farzipour S, Alvandi M (2022). Etodolac Enhances the Radiosensitivity of Irradiated Ht-29 Human Colorectal Cancer Cells. Current Radiopharmaceuticals, 15(3), 242-248. |
Chicago | Shaghaghi Z, Polgardani NZ, Abbasi S, Albooyeh H, Dastranj L, Farzipour S, Alvandi M. "Etodolac Enhances the Radiosensitivity of Irradiated Ht-29 Human Colorectal Cancer Cells." Current Radiopharmaceuticals 15, no. 3 (2022): 242-248. |
Harvard | Shaghaghi Z et al. (2022) 'Etodolac Enhances the Radiosensitivity of Irradiated Ht-29 Human Colorectal Cancer Cells', Current Radiopharmaceuticals, 15(3), pp. 242-248. |
Vancouver | Shaghaghi Z, Polgardani NZ, Abbasi S, Albooyeh H, Dastranj L, Farzipour S, et al.. Etodolac Enhances the Radiosensitivity of Irradiated Ht-29 Human Colorectal Cancer Cells. Current Radiopharmaceuticals. 2022;15(3):242-248. |
BibTex | @article{ author = {Shaghaghi Z and Polgardani NZ and Abbasi S and Albooyeh H and Dastranj L and Farzipour S and Alvandi M}, title = {Etodolac Enhances the Radiosensitivity of Irradiated Ht-29 Human Colorectal Cancer Cells}, journal = {Current Radiopharmaceuticals}, volume = {15}, number = {3}, pages = {242-248}, year = {2022} } |
RIS | TY - JOUR AU - Shaghaghi Z AU - Polgardani NZ AU - Abbasi S AU - Albooyeh H AU - Dastranj L AU - Farzipour S AU - Alvandi M TI - Etodolac Enhances the Radiosensitivity of Irradiated Ht-29 Human Colorectal Cancer Cells JO - Current Radiopharmaceuticals VL - 15 IS - 3 SP - 242 EP - 248 PY - 2022 ER - |